Fresenius Medical Care (ETR:FME) Hits New 12-Month High – Time to Buy?

Fresenius Medical Care AG (ETR:FME) reached a new 52-week high on Monday . The stock traded as high as €43.18 ($45.45) and last traded at €43.09 ($45.36), with a volume of 430316 shares traded. The stock had previously closed at €41.60 ($43.79).

Fresenius Medical Care Stock Performance

The company has a debt-to-equity ratio of 77.56, a quick ratio of 0.80 and a current ratio of 1.46. The stock has a market cap of $12.64 billion, a PE ratio of 23.81, a P/E/G ratio of 0.42 and a beta of 0.86. The business’s fifty day moving average price is €38.79 and its 200-day moving average price is €37.44.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.